Navigation Links
DRAXIS Share Buyback Approved by TSX
Date:1/16/2008

s only as of the date made.

These statements are not guarantees of future performance. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks, uncertainties and other factors that may cause the actual results or performance of the Company to be materially different from such statements or from any future results or performance implied thereby. Factors that could cause the Company's results or performance to differ materially from a conclusion, forecast or projection in the forward-looking statements include, but are not limited to:

- the achievement of desired clinical trial results related to the

Company's pipeline products;

- timely regulatory approval of the Company's products;

- the ability to comply with regulatory requirements applicable to the

manufacture and marketing of the Company's products;

- the Company's ability to obtain and enforce effective patents;

- the non-infringement of third party patents or proprietary rights by

the Company and its products;

- factors beyond our control that could cause interruptions in our

operations in our single manufacturing facility (including, without

limitation, material equipment breakdowns);

- reimbursement policies related to health care;

- the establishment and maintenance of strategic collaborative and

commercial relationships;

- the Company's dependence on a small number of key customers;

- the disclosure of confidential information by our collaborators,

employees or consultants;

- the preservation of healthy working relationships with the Company's

union and employees;

- the Company's ability to grow the business;

- the fluctuation of our financial results and exchange and interest

rate fluctuations;

- the adaptation to changing technologies;

- the loss of ke
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DRAXIS Announces Application for Normal Course Issuer Bid
2. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
5. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
6. Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options
7. AlphaRx CEO Accumulates More Company Shares
8. Private Equitys Top Execs to Share Advice, Candid Predictions at 2008 Outlook Conference
9. HearAtLast Holdings, Inc. Provides Shareholder Update
10. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
11. Body Abnormalities, Childhood Cancer May Share Genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015 Mutare Health, a ... nationally-renowned Gastroenterologist Lawrence Kosinski, MD, MBA, AGAF, to ... Kosinski brings a unique combination of medical experience, ... Mutare Health team as it continues ... and quality of care in the healthcare environment. ...
(Date:4/20/2015)... 20, 2015 Novatus, a leading ... expanded its service level to the growing European ... Amsterdam and Paris. After a rigorous review ... levels of resilience, security and operational expertise, and ... for Novatus as we expand our footprint and ...
(Date:4/20/2015)... York (PRWEB) April 20, 2015 ... representing the U.S. health insurance industry, is seeking ... of the recent controversy involving surgical tools called ... to U.S. Senator Robert Casey (D-PA) dated April ... surrounding uterine morcellation point to “serious gaps in ...
(Date:4/20/2015)... 1% for the Planet , one of ... Kate Williams, the network’s Director of Partnerships, will step into ... has been part of 1% for the Planet since early ... the Northern Forest Canoe Trail, a 1% for the Planet ... stewardship of and advocacy for the outdoors, a commitment which ...
(Date:4/20/2015)... Grateful Dead originally formed in 1965 in ... The group was more than just about rock music. They ... rock, country, and other genres to put together their greatest ... group was inducted into the Rock and Roll Hall of ... 35 million records worldwide. This year marks the 50th ...
Breaking Medicine News(10 mins):Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:Novatus Expands into European Data Centers 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2
... take place at the RAI Exhibition and Congress Centre ... 6 May to Saturday 9 May 2009. , Excess ... chronic diseases, including diabetes, heart disease, stroke and cancer, ... death worldwide. With global rates in adults and children ...
... while reporting in Iraq in 2006, he suffered severe head ... and produce common words a condition called aphasia. Today, ... intensive behavioral therapy reading and repeating words and sounds. ... has always been and will always be speech/language therapy, but ...
... State Commander of the Indiana American Legion reacted angrily ... face" to supporters of the Indiana Soldiers and Sailors ... request to our Department Adjutant, The American Legion devoted ... down the Home, and what do we get in ...
... Feb. 17 Rodan + Fields Dermatologists, the ... -trained dermatologists Katie Rodan, M.D. and Kathy Fields, ... Vice President of Sales. In his new ... Training, Regional Field Development, Events, Recognition and Incentive ...
... 17 ORTHOWORLD is pleased to announce the opening ... Orthopaedic Manufacturing & Technology Exposition and Conference. This year,s ... the Donald E. Stephens Convention Center in Rosemont, Illinois. ... hundreds of orthopaedic industry professionals involved in all facets ...
... PhD, Professor of Pediatrics and Genetics at LSU Health Sciences ... revealing the molecular mechanism of how a protein determines the ... Zinc Finger Transcription Factor INSM1 Interrupts Cyclin D1 and CDK4 ... currently available online, will be published in the Journal ...
Cached Medicine News:Health News:ECO 2009 -- The 17th European Congress on obesity 2Health News:Exploring new pathways to language 2Health News:Legion Condemns Governor's Non-Response to ISSCH Proposal As 'Slap In The Face' 2Health News:Christian Diaz Joins Rodan + Fields(R) Dermatologists as Vice President of Sales 2Health News:OMTEC Registration Opens - Education for a Competitive Advantage in Orthopaedics 2Health News:LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth 2
(Date:4/20/2015)... , April 20, 2015 Merrimack ... final clinical results for the Phase 1 study ... HER2-positive metastatic breast cancer.  The results were presented ... trials plenary oral session at the 2015 American ... Philadelphia, PA. Data described ...
(Date:4/20/2015)... NEW YORK , April 20, 2015 ... Rental and Leasing in US$ Million. The report provides ... , Europe , and Rest ... the period 2014 through 2020. Also, a seven-year historic ... analytics are derived from primary and secondary research. Company ...
(Date:4/20/2015)... -- This report analyzes the worldwide markets for Blood Pressure ... Product Segments: Sphygmomanometers (Aneroid Sphygmomanometers, & Digital Sphygmomanometers), Ambulatory and ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle East ... estimates and forecasts are provided for the period 2014 through ...
Breaking Medicine Technology:Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26
... Holdings, Inc. (the "Company") today announced its operating results for the ... Months Ended September 30, 2009 , Net ... $1.9 million, or 2.3%, for the three months ended September 30, ... in 2008. Patient days and admissions decreased by 4.4% and 7.2%, ...
... Quantros, a leading software and services provider for ... with Det Norske Veritas Healthcare, Inc. (DNV). DNV ... Medicare and Medicaid Services (CMS) as an authorized ... accreditation standards into the Quantros ACE(TM) software application. ...
Cached Medicine Technology:LifeCare Holdings, Inc. Announces Third Quarter Results 2LifeCare Holdings, Inc. Announces Third Quarter Results 3LifeCare Holdings, Inc. Announces Third Quarter Results 4LifeCare Holdings, Inc. Announces Third Quarter Results 5LifeCare Holdings, Inc. Announces Third Quarter Results 6LifeCare Holdings, Inc. Announces Third Quarter Results 7LifeCare Holdings, Inc. Announces Third Quarter Results 8LifeCare Holdings, Inc. Announces Third Quarter Results 9LifeCare Holdings, Inc. Announces Third Quarter Results 10LifeCare Holdings, Inc. Announces Third Quarter Results 11LifeCare Holdings, Inc. Announces Third Quarter Results 12LifeCare Holdings, Inc. Announces Third Quarter Results 13LifeCare Holdings, Inc. Announces Third Quarter Results 14LifeCare Holdings, Inc. Announces Third Quarter Results 15Quantros Announces Partnership With Hospital Accreditation Agency DNV 2
Bio-Rad's Liquichek™ D-dimer Control provides the laboratory with a liquid, trilevel, human plasma based control for the monitoring of D-dimer testing on most automated coagulation, chemistry a...
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek Diabetes Control is a human whole blood based product used to monitor hemoglobin fractions associated with diabetes, including Hemoglobins A1, A1C, F and Total Glycated Hemoglobin....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Medicine Products: